FeNO by NIOX® UK

FeNO by NIOX® UK is a brand under Niox Group Plc, a UK-based company dedicated to improving respiratory health through innovative medical devices. Headquartered in Oxford, Niox Group specializes in the design, development, and commercialization of point-of-care devices that measure fractional exhaled nitric oxide (FeNO), a key biomarker for airway inflammation. The flagship product, the NIOX VERO® device, offers a non-invasive and user-friendly way to measure FeNO levels in patients' breath. This technology aids healthcare professionals in accurately diagnosing and managing asthma by providing clear insights into airway inflammation. The device is designed to enhance usability with visual aids and sounds, making the testing process straightforward for patients. Niox Group's products are available in over 50 countries, supported by local teams and distributors to ensure effective customer service. Niox Group collaborates with healthcare professionals, including pulmonologists and allergists, to improve asthma care and patient outcomes. The company also partners with pharmaceutical firms like AstraZeneca to support respiratory disease management initiatives.

• Employees 6
• Founded 2006